News Watch-List: HCA Healthcare, Inc. (NYSE: HCA)

HCA Healthcare, Inc. (NYSE: HCA) observed a climb of 0.46% on FRIDAY trading period with closing price of $136.84. The company’s last traded volume of 879565 shares vs to an average volume of 1461.57K shares. The stock as of last trading session moved at 24.05% from its 52-week low and was trading at -7.18% to its 52-week high.

HCA Healthcare, Inc. (HCA) recently reported financial and operating results for the third quarter ended September 30, 2019.

Key third quarter metrics (all percentage changes compare 3Q 2019 to 3Q 2018 unless otherwise noted):

  • Revenues totaled $12.694B
  • Net income attributable to HCA Healthcare, Inc. totaled $612M, or $1.76 per diluted share
  • Adjusted EBITDA totaled $2.285B
  • Cash flows from operating activities totaled $2.126B
  • Same facility equivalent admissions and same facility admissions increased 4.2 percent and 3.2 percent, respectively

Revenues in the third quarter of 2019 increased to $12.694B, contrast to $11.451B in the third quarter of 2018. Net income attributable to HCA Healthcare, Inc. totaled $612M, or $1.76 per diluted share, contrast to $759M, or $2.15 per diluted share, in the third quarter of 2018. Results for the third quarter of 2019 include losses on retirement of debt of $211M, or $0.47 per diluted share. Third quarter of 2018 results included gains on sales of facilities of $6M, or $0.01 per diluted share, and losses on retirement of debt of $9M, or $0.02 per diluted share.

For the third quarter of 2019, Adjusted EBITDA totaled $2.285B, contrast to $2.096B in the third quarter of 2018. Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information on Adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc. to Adjusted EBITDA is included in this release.

Same facility admissions and equivalent admissions increased 3.2 percent and 4.2 percent, respectively, in the third quarter of 2019 contrast to the previous year period. Same facility emergency room visits increased 4.1 percent in the third quarter of 2019, contrast to the previous year period. Same facility inpatient surgeries increased 2.2 percent, and same facility outpatient surgeries increased 2.6 percent in the third quarter of 2019, contrast to the same period of 2018. Same facility revenue per equivalent admission increased 2.0 percent in the third quarter of 2019, contrast to the third quarter of 2018.

Salaries and benefits, supplies and other operating expenses totaled $10.413B, or 82.0 percent of revenues, in the third quarter of 2019, contrast to $9.364B, or 81.8 percent of revenues, in the third quarter of 2018.

Nine Months Ended September 30, 2019

Revenues for the nine months ended September 30, 2019 totaled $37.813B, contrast to $34.403B in the same period of 2018. Net income attributable to HCA Healthcare, Inc. was $2.434B, or $6.98 per diluted share, contrast to $2.723B, or $7.65 per diluted share, for the first nine months of 2018. Results for the nine months ended September 30, 2019 include gains on sales of facilities of $17M, or $0.04 per diluted share and losses on retirement of debt of $211M, or $0.47 per diluted share. Results for the nine months ended September 30, 2018 included gains on sales of facilities of $420M, or $0.89 per diluted share, and losses on retirement of debt of $9M, or $0.02 per diluted share.

EPS growth for this year is 34.70% and EPS growth for next year is expected to reach at 10.51%. EPS growth in past five years was 22.00% while EPS growth in next five years is projected to arrive at 9.92%. Sales growth past 5 years was measured at 6.40%.

 

Leave a Reply

Your email address will not be published. Required fields are marked *